This Study Demonstrates That Treatment With CB1 Antagonist AM251 Improves Renal Outcomes In Obese Rats

Kidney Disease (Obesity-Related Kidney Dysfunction)

Key Findings

This study demonstrates that treatment with CB1 antagonist AM251 improves renal outcomes in obese rats.

Information and Links


Link: This Study Demonstrates That Treatment With CB1 Antagonist AM251 Improves Renal Outcomes In Obese Rats

Year: 2015

DOI: 10.1530/JOE-15-0004


Ratings

(How Ratings Work)

Kidney Disease (Obesity-Related Kidney Dysfunction) — 2


Possible to probable range of efficacy of cannabis for treatment of Kidney Disease (Obesity-Related Kidney Dysfunction) according to the results found in this study.

Drugs Used

AM251